{
  "docId": "019de076-48c2-7315-bf77-72d2721572a4",
  "docSlug": "9ba2b11c98152a86fe4ad3555ff50f91",
  "documentTitle": "Immatics | Investor Presentation Deck | 75 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 37,
  "pageCount": 75,
  "prevPage": 36,
  "nextPage": 38,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 48,
  "notes": "The table uses a multi-step funnel approach to arrive at the final patient population count.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-48c2-7315-bf77-72d2721572a4/37",
  "deckHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4",
  "deckJsonHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4.json",
  "deckAnchorHref": "/decks/019de076-48c2-7315-bf77-72d2721572a4#slide-37",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.95,
        "x": 0.04,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "Incidences based on public estimates and Immatics internal model; Relapsed/refractory (R/R) or last-line patient population approximated by annual mortality; Estimated 41% HLA-A*02:01 positive population in the US; PRAME target prevalence is based on TCGA...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ab2d051-2aaf-461f-85fa-9600c0ba0622",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.65,
        "x": 0.04,
        "y": 0.72
      },
      "kind": "list",
      "text": "Multiple opportunities to broaden patient reach and patient benefit: Expand beyond US population; Expand into other indications; Move into earlier lines of therapy; Inclusion of patients with lower PRAME-threshold",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01835e54-a6af-421e-ac96-d4dec50191fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.74,
        "x": 0.13,
        "y": 0.2
      },
      "kind": "table",
      "text": "Selected Indications, Incidence, R/R Incidence, PRAME Positive, Patient Population",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf720063-e2b7-4d2d-8483-d0bdd08c64ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "title",
      "text": "~39,000 Patients per Year in the US only",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eca96673-4fa6-4aa7-82e8-fd0420d777a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.75,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "IMA203 TCR-T Has the Potential to Reach a Large Patient Population",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28c6b02d-5f2d-4441-b8b1-80582ebc4b4e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "market-segmentation-pyramid",
      "slug": null,
      "matchId": "0adc99bd-839d-4f56-9a19-1af8fa3b0385",
      "evidence": "The table segments the total addressable market into specific indications and filters by clinical criteria (R/R, PRAME+).",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 37,
      "from": 34,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "bd9bf9fa-635b-43ba-9ce8-c44ac7fb007c",
      "evidence": "The loop is visible in the section on potential of IMA203 in additional solid cancer indications.",
      "position": 1,
      "objective": "Show potential for large patient populations",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}